Mark Prausnitz

Mark Prausnitz

The Mark Prausnitz lab developed the STAR particles that form the foundation of a new company, Aldena Therapeutics, that recently received $30 million in venture capital funding.

Additional Information

Groups

Parker H. Petit Institute for Bioengineering and Bioscience (IBB), Research Horizons

Categories
No categories were selected.
Keywords
No keywords were submitted.
Status
  • Created By: Jerry Grillo
  • Workflow Status: Published
  • Created On: Dec 22, 2021 - 9:21am
  • Last Updated: Dec 22, 2021 - 9:24am